ArticlePathogens and global health2015
The cost of an Ebola case.
Article in Pathogens and global health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Investigation of the Status of Epidemiology, Pathophysiology, Virology, Clinical Symptoms, Diagnosis, Prevention, Treatment and Classification of Ebola Virus Disease (EVD): A Systematic Review.Infectious disorders drug targets · 2025Pooled it
- Recent Advances in Biosensors for Detection of COVID-19 and Other Viruses.IEEE reviews in biomedical engineering · 2023Pooled it
- CD4Nature immunology · 2026Article
- Contrasting the impact and cost-effectiveness of successive intervention strategies in response to Ebola in the Democratic Republic of the Congo, 2018-2020.BMJ global health · 2025Article
- Article
- A Framework for Assessing the Impact of Outbreak Response Immunization Programs.Diseases (Basel, Switzerland) · 2024Article
- The effect of governance structures on optimal control of two-patch epidemic models.Journal of mathematical biology · 2023Article
- The cost of public health interventions to respond to the 10th Ebola outbreak in the Democratic Republic of the Congo.BMJ global health · 2023Article
- Modelling the economic burden of SARS-CoV-2 infection in health care workers in four countries.Nature communications · 2023Article
- Article
- The economic value of personal protective equipment for healthcare workers.PLOS global public health · 2023Article
- Economic burden of public health care and hospitalisation associated with COVID-19 in China.Public health · 2022Article
- The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States.Health affairs (Project Hope) · 2020Review
- An introduction to economic studies, health emergencies, and COVID-19.Journal of evidence-based medicine · 2020Article
- Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.Pathogens (Basel, Switzerland) · 2020Article
- Costs and benefits of early response in the Ebola virus disease outbreak in Sierra Leone.Cost effectiveness and resource allocation : C/E · 2020Article
- The monetary value of human lives lost through Ebola virus disease in the Democratic Republic of Congo in 2019.BMC public health · 2019Article
- Sexual transmission and the probability of an end of the Ebola virus disease epidemic.Journal of theoretical biology · 2019Article
- Ebola Virus Disease Preparations Do Not Protect the United States Against Other Infectious Outbreaks.American journal of public health · 2018Article
- Global Health Solidarity.Public health ethics · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
As the most recent outbreak of Ebola virus disease (EVD) in West Africa continues to grow since its initial recognition as a Public Health Emergency of International Concern, an unanswered question is what is the cost of a case of Ebola? Understanding this cost will help decision makers better understand the impact of each case of EVD, benchmark this against that of other diseases, prioritize which cases may require response, and begin to estimate the cost of Ebola outbreaks. To date, the scientific literature has not characterized this cost per case. Therefore, we developed a mathematical model to estimate the cost of an EVD case from the provider and societal perspectives in the three most affected countries of Guinea, Liberia, and Sierra Leone. Our model estimates the total societal cost of an EVD case with full recovery ranges from $480 to $912, while that of an EVD case not surviving ranges from $5929 to $18 929, varying by age and country. Therefore, as of 10 December 2014, the estimated total societal costs of all reported EVD cases in these three countries range from $82 to potentially over $356 million.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.